Exciting news from HarmonyCares as they announce a staggering $200 million raised in funding. Founded in 1993, HarmonyCares has been a leading provider of comprehensive home-based healthcare services, catering to older adults and individuals with complex medical conditions. With a focus on delivering top-quality care in the comfort of patients' homes, the company has made it their mission to enhance convenience, outcomes, and overall satisfaction for those in need of medical support. The generous funding will further propel HarmonyCares' innovative care model which includes primary care, lab and radiology services, skilled home health care, palliative and hospice care, as well as comprehensive health assessments. Currently operating in several states across the U.S., including Florida, Georgia, and Texas, HarmonyCares will utilize the raised capital to expand their reach and continue to provide exceptional care to those who need it most. This significant investment underscores the confidence investors have in HarmonyCares' vision and dedication to improving healthcare delivery.
HarmonyCares Secures $200M Series B Funding for Innovative Home-Based Healthcare Services
Recently funded 路 $200.0M Series bHealthcare
Get the full HarmonyCares company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Aisot Technologies
Aisot Technologies is a Zurich-based AI company pioneering advanced, AI-driven investment solutions. Spun out of ETH Zurich in 2021, aisot leverages machine learning, large language models (LLMs), and quantitative methods to deliver precise, real-time investment insights. Its AI Insights Platform empowers asset managers, funds, family offices, and treasuries to anticipate market trends, optimize strategies, and mitigate risk. Recognized across Europe and the U.S., aisot partners with leading financial institutions to redefine quantitative investment management.
$2.5M Seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
Other recent Series b rounds
Companies that recently closed a Series b round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  NEW ID | Series b | $705.2K | today |
| 2 |  Arist United States | Series b | $14.1M | today |
| 3 |
